Mucosal lymphoid infiltrate dominates colonic pathological changes in murine experimental Shigellosis

Journal of Infectious Diseases

Volumn 192, Issue 1, 2005, Pages 136-148

  Martino, Maria Celeste ^a   Rossi, Giacomo ^b   Martini, Irene ^a   Tattoli, Ivan ^a   Chiavolini, Damiana ^c   Phalipon, Armelle ^d   Sansonetti, Philippe J ^d   Bernardini, Maria Lina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CECUM; CELL POPULATION; COLON MUCOSA; COLONY FORMING UNIT; CONTROLLED STUDY; EPITHELIUM CELL; FECES ANALYSIS; FEMALE; HISTOPATHOLOGY; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; INFECTION SENSITIVITY; LYMPH FOLLICLE; LYMPHADENITIS; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHIGELLA FLEXNERI; SHIGELLOSIS; STRAIN DIFFERENCE;

ANIMALS; APOPTOSIS; COLON; DYSENTERY, BACILLARY; FECES; FEMALE; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; NEUTROPHILS; SHIGELLA FLEXNERI;

EID: 20844458270     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430740     Document Type: Article

References (43)

1. Mathan VI, Mathan MM. Intestinal manifestations of invasive diarrheas and their diagnosis. Rev Infect Dis 1991; 13(Suppl 4):S311-3.
2. DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989; 159:1126-8.
3. Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77:651-6.
4. Sansonetti PJ, Arondel J, Fontaine A, d'Hauteville H, Bernardini ML. ompB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis. Vaccine 1991; 9:416-22.
5. Buttner D, Bonas U. Port of entry: the type III secretion translocon. Trends Microbiol 2002; 10:186-92.
6. Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature 1992;358:167-9.
7. Zychlinsky A, Fitting C, Cavaillon JM, Sansonetti PJ. Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J Clin Invest 1994; 94:1328-32.
8. Arondel J, Singer M, Matsukawa A, Zychlinsky A, Sansonetti PJ. Increased interleukin 1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental shigellosis. Infect Immun 1999;67:6056-66.
9. Sansonetti PJ, Arondel J, Huerre M, Harada A, Matsushima K. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect Immun 1999; 67:1471-80.
10. Philpott DJ, Yamaoka S, Israel A, Sansonetti PJ. Invasive Shigella flexneri activates NF-kappaB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol 2000; 165:903-14.
11. Girardin SE, Boneca IG, Carneiro LA, et al. Nod1 detects a unique muropeptide from gram negative bacterial peptidoglycan. Science 2003; 300:1584-7.
12. Girardin SE, Tournebize R, Mavris M, et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2001;2:736-42.
13. Perdomo OJ, Cavaillon JM, Huerre M, Ohayon H, Gounon P, Sansonetti PJ. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med 1994; 180:1307-19.
14. Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M. Role of IL-1 in the pathogenesis of experimental shigellosis. J Clin Invest 1995; 96:884-92.
15. Sansonetti PJ, Phalipon A, Arondel J, et al. Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 2000; 12:581-90.
16. Weinrauch Y, Drujan D, Shapiro SD, Weiss J, Zychlinsky A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 2002; 417: 91-4.
17. Voino-Yasenetsky MV, Voino-Yasenetskaya MK. Experimental pneumonia caused by bacteria of Shigella group. Acta Morphol Acad Sci Hung 1962; 11:439-54.
18. Phalipon A, Kaufmann M, Michetti P, et al. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med 1995; 182:769-78.
19. Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A, Sansonetti PJ. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell Microbiol 2003; 5:481-91.
20. Singer M, Sansonetti PJ. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J Immunol 2004;173:4197-206.
21. Allaoui A, Mounier J, Prevost C, Sansonetti PJ, Parsot C. icsB: a Shigella flexneri virulence gene necessary for the lysis of protrusions during intercellular spread. Mol Microbiol 1992; 6:1605-16.
22. Sansonetti PJ, Kopecko DJ, Formal SB. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun 1982; 35:852-60.
23. Buchrieser C, Glaser P, Rusniok C, et al. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol Microbiol 2000; 38:760-71.
24. Cersini A, Martino MC, Martini I, Rossi G, Bernardini ML. Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants. Infect Immun 2003;71:7002-13.
25. Miller JH. A short course in bacterial genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1992.
26. Martino MC, Rossi G, Tattoli I, et al. Intravenous infection of virulent shigellae causes fulminant hepatitis in mice. Cell Microbiol 2005; 7: 115-27.
27. Dixon MF, Genta RM, Yardley JF, Correa P. Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 1996; 20: 1161-81.
28. Happonen I, Linden J, Saari S, et al. Detection and effects of helicobacters in healthy dogs and dogs with signs of gastritis. J Am Vet Med Assoc 1998; 213:1767-74.
29. Etheridge ME, Hoque AT, Sack DA. Pathologic study of a rabbit model for shigellosis. Lab Anim Sci 1996; 46:61-6.
30. Bernardini ML, Arondel J, Martini I, Aidara A, Sansonetti PJ. Parameters underlying successful protection with live attenuated mutants in experimental shigellosis. Infect Immun 2001; 69:1072-83.
31. Brown KJ, Tannock GW, Eyres RA, Elliott RB, Lines R. Colonization of Salmonella typhimurium and Shigella flexneri III of the gastrointestinal tract of mice treated with beta-2-thienylalanine and streptomycin. Antonie Van Leeuwenhoek 1979; 45:531-46.
32. Que JU, Casey SW, Hentges DJ. Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun 1986; 53:116-23.
33. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 2003; 71:2839-58.
34. Zhang Z, Jin L, Champion G, Seydel KB, Stanley SL Jr. Shigella infection in SCID-HU-INT mice: role for neutrophils in containing bacterial dissemination in human intestine. Infect Immun 2001; 69:3240-7.
35. Way SS, Borczuk AC, Goldberg MB. An essential role for gamma Interferon in innate resistance to Shigella flexneri infection. Infect Immun 1998; 66:1342-8.
36. Raqib R, Ljungdahl A, Lindberg AA, Andersson U, Andersson J. Local entrapment of Interferon gamma in the recovery from Shigella dysenteriae type 1 infection. Gut 1996; 38:328-36.
37. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2:957-60.
38. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195:327-33.
39. Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect Immun 1997; 65:739-49.
40. Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182:190-200.
41. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2:389-400.
42. Kantor AB, Herzemberg LA. Origin of murine B-cell lineages. Annu Rev Immunol 1993; 11:501-38.
43. Carroll MC, Prodeus AP. Linkages of innate and adaptive immunity. Curr Opin Immunol 1998; 10:36-40.